DUBLIN--(BUSINESS WIRE)--The "Nebulizers - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
"Nebulizers - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Nebulizers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Nebulizer is a device which helps in direct delivery of medicine in case of respiratory disorders. It turns liquid medicine into mist (aerosol) to treat asthma, COPD, cystic fibrosis, and other respiratory disorders.
Scope
- Extensive coverage of the Nebulizers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Nebulizers Overview
3 Products under Development
3.1 Nebulizers - Pipeline Products by Stage of Development
3.2 Nebulizers - Pipeline Products by Segment
3.3 Nebulizers - Pipeline Products by Territory
3.4 Nebulizers - Pipeline Products by Regulatory Path
3.5 Nebulizers - Pipeline Products by Estimated Approval Date
3.6 Nebulizers - Ongoing Clinical Trials
4 Nebulizers - Pipeline Products under Development by Companies
4.1 Nebulizers Companies - Pipeline Products by Stage of Development
4.2 Nebulizers - Pipeline Products by Stage of Development
5 Nebulizers Companies and Product Overview
5.1 Ablynx NV Company Overview
5.2 Aeon Research & Technology Company Overview
5.3 AFT Pharmaceuticals Ltd Company Overview
5.4 Aura Medical Company Overview
5.5 Baby's Breath Ltd. Company Overview
5.6 Bridgesource Medical Corp Company Overview
5.7 Creare LLC Company Overview
5.8 DesignWise Medical Inc (Inactive) Company Overview
5.9 HCmed Innovations Co Ltd Company Overview
5.10 Marquette University Company Overview
5.11 Parion Sciences Inc Company Overview
5.12 RMIT University Company Overview
5.13 SolAeroMed Inc Company Overview
5.14 Stirling Pharma Inc Company Overview
5.15 Teleflex Inc Company Overview
5.16 University of California San Diego Company Overview
5.17 University of Texas Medical Branch at Galveston Company Overview
5.18 Verona Pharma Plc Company Overview
5.19 Vincent Medical Holdings Ltd Company Overview
5.20 Wellinks Inc Company Overview
6 Nebulizers- Recent Developments
6.1 Feb 17, 2021: U of M's Technological Leadership Institute names Professor Allison Hubel new director
6.2 Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
6.3 Feb 16, 2021: Owens & Minor will Report Fourth Quarter & Full Year Financial Results on Wednesday, February 24, 2021
6.4 Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
6.5 Feb 05, 2021: Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021
6.6 Feb 04, 2021: Cardinal Health Earnings Preview
6.7 Jan 12, 2021: Vectura Group: Trading update
6.8 Sep 09, 2020: AstraZeneca Alliance and NEBUCOR nebulizers subscribe for the benefit of asthma patients
7 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/wb35w4
